Publicaciones en colaboración con investigadores/as de Jagiellonian University (93)

2024

  1. Complete vs Culprit-Only Revascularization in Older Patients with Myocardial Infarction and High Bleeding Risk: A Randomized Clinical Trial

    JAMA Cardiology, Vol. 9, Núm. 6, pp. 565-573

  2. Correction to: Optical coherence tomography in coronary atherosclerosis assessment and intervention (Nature Reviews Cardiology, (2022), 19, 10, (684-703), 10.1038/s41569-022-00687-9)

    Nature Reviews Cardiology

  3. Factors Associated With Coronary Angiography Performed Within 6 Months of Randomization to the Conservative Strategy in the ISCHEMIA Trial

    Circulation: Cardiovascular Interventions, Vol. 17, Núm. 6, pp. 457-473

  4. Global Consensus Recommendations on Improving the Safety of Chronic Total Occlusion Interventions

    Heart Lung and Circulation, Vol. 33, Núm. 7, pp. 915-931

  5. Health-Status Outcomes in Older Patients with Myocardial Infarction: Physiology-Guided Complete Revascularization Versus Culprit-Only Strategy

    Circulation: Cardiovascular Quality and Outcomes, Vol. 17, Núm. 7, pp. e010490

  6. Incidence, risk factors, and outcomes of second neoplasms in patients with acute promyelocytic leukemia: the PETHEMA-PALG experience

    Annals of Hematology, Vol. 103, Núm. 2, pp. 451-461

  7. Ticagrelor with or without aspirin following percutaneous coronary intervention in high-risk patients with concomitant peripheral artery disease: A subgroup analysis of the TWILIGHT randomized clinical trial

    American Heart Journal, Vol. 272, pp. 11-22

2023

  1. A pleiotropic variant in DNAJB4 is associated with multiple myeloma risk

    International Journal of Cancer, Vol. 152, Núm. 2, pp. 239-248

  2. Applied coronary physiology for planning and guidance of percutaneous coronary interventions. A clinical consensus statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the European Society of Cardiology

    EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, Vol. 19, Núm. 6, pp. 464-481

  3. Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension: a clinical consensus statement of the ESC working group on pulmonary circulation and right ventricular function

    European heart journal, Vol. 44, Núm. 29, pp. 2659-2671

  4. Bleeding and Ischemic Risks of Ticagrelor Monotherapy After Coronary Interventions

    Journal of the American College of Cardiology, Vol. 82, Núm. 8, pp. 687-700

  5. Care of patients with ST-elevation myocardial infarction: an international analysis of quality indicators in the acute coronary syndrome STEMI Registry of the EURObservational Research Programme and ACVC and EAPCI Associations of the European Society of Cardiology in 11 462 patients

    European Heart Journal: Acute Cardiovascular Care, Vol. 12, Núm. 1, pp. 22-37

  6. Clinically Driven Revascularization in High-Risk Patients Treated With Ticagrelor Monotherapy After PCI: Insights from the Randomized TWILIGHT Trial

    American Journal of Cardiology, Vol. 208, pp. 16-24

  7. Complete or Culprit-Only PCI in Older Patients with Myocardial Infarction

    New England Journal of Medicine, Vol. 389, Núm. 10, pp. 889-898

  8. Dyspnea-Related Ticagrelor Discontinuation After Percutaneous Coronary Intervention

    JACC: Cardiovascular Interventions, Vol. 16, Núm. 20, pp. 2514-2524

  9. Food-Induced Anaphylaxis: Data From the European Anaphylaxis Registry

    Journal of Allergy and Clinical Immunology: In Practice, Vol. 11, Núm. 7, pp. 2069-2079.e7

  10. Identification of novel genetic loci for risk of multiple myeloma by functional annotation

    Leukemia

  11. Long-term outcomes of patients with normal fractional flow reserve and thin-cap fibroatheroma

    EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, Vol. 18, Núm. 13, pp. e1099-e1107

  12. Management strategies for heavily calcified coronary stenoses: an EAPCI clinical consensus statement in collaboration with the EURO4C-PCR group

    European heart journal, Vol. 44, Núm. 41, pp. 4340-4356

  13. More Than 2% of Circulating Tumor Plasma Cells Defines Plasma Cell Leukemia-Like Multiple Myeloma

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 41, Núm. 7, pp. 1383-1392